|
KIAA1468 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.238400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.266490E-02 |
| Normal-vs-Stage2 |
3.019800E-01 |
| Normal-vs-Stage3 |
7.563700E-02 |
| Normal-vs-Stage4 |
7.39509999903021E-08 |
| Stage1-vs-Stage2 |
7.055200E-01 |
| Stage1-vs-Stage3 |
4.590800E-01 |
| Stage1-vs-Stage4 |
5.041500E-04 |
| Stage2-vs-Stage3 |
3.600000E-01 |
| Stage2-vs-Stage4 |
6.384300E-03 |
| Stage3-vs-Stage4 |
1.009200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.289790E-02 |
| Normal-vs-AfricanAmerican |
2.493500E-02 |
| Normal-vs-Asian |
1.534240E-02 |
| Caucasian-vs-AfricanAmerican |
7.665600E-01 |
| Caucasian-vs-Asian |
5.996600E-01 |
| AfricanAmerican-vs-Asian |
6.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.543600E-03 |
| Normal-vs-Female |
3.140800E-01 |
| Male-vs-Female |
2.655400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.651600E-02 |
| Normal-vs-Extreme_Weight |
3.704900E-03 |
| Normal-vs-Obese |
1.751840E-02 |
| Normal-vs-Extreme_Obese |
7.214800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.386800E-01 |
| Normal_Weight-vs-Obese |
9.846000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.974200E-01 |
| Extreme_Weight-vs-Obese |
5.732600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.740600E-01 |
| Obese-vs-Extreme_Obese |
4.605800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.154610E-01 |
| Normal-vs-Age(41-60Yrs) |
1.762030E-01 |
| Normal-vs-Age(61-80Yrs) |
6.935400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.680390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.934600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.825800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.846600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.065000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.428580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.121000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.373380E-01 |
| Normal-VS-Type2 PRCC |
1.249490E-04 |
| Normal-VS-KIRP CIMP |
1.81133999999084E-05 |
| Normal-VS-Unclassified PRCC |
6.397800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.100000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.824500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.592200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.491000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.766100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.132000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.303200E-03 |
| Normal-vs-N1 |
1.235180E-04 |
| Normal-vs-N2 |
3.617800E-04 |
| N0-vs-N1 |
1.741840E-01 |
| N0-vs-N2 |
1.989990E-01 |
| N1-vs-N2 |
4.685400E-01 |
|
|
